Publication | Closed Access

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMitochondrial InhibitorsMyeloid NeoplasiaPharmacotherapyCombination TherapyAdaptive ResistanceAdult T-cell Leukemia-lymphomaPharmacologyRadiation OncologyHealth Sciences